Carvalho AF
IMPACT (Innovation in Mental and Physical Health and Clinical Treatment) Strategic Research Centre, School of Medicine, Barwon Health, Deakin University, Geelong, VIC, Australia.
PreprintKetamine
<i>In Vitro</i> Ketamine Attenuates Immune Sensitization in Major Depressive Disorder in a Concentration-Dependent Manner
ArticlePsilocybin
Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.
ArticlePsilocybin
Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.
ArticlePsilocybin